New drugs to treat bladder, endometrial, and non-small cell lung cancer and melanoma were approved.

Dr. Faith E. Davies discusses the approval of second CAR T-cell therapy for multiple myeloma.

People receive world-class care at Long Island’s only full-service NCI-designated Comprehensive Cancer Center.

Dr. Nancy Chan selects clinical trials that best serve the diverse patient population.

Dr. Faith E. Davies will oversee development of a biospecimens resource for research on blood cancers.

The therapy is a potential game changer for treating this common form of bladder cancer.

Study shows that new combination of drugs is safe and effective in helping stem cell transplantation.

An octogenarian beats back prostate cancer with a bold treatment plan at Perlmutter Cancer Center.

Identifying the mutation type in HER2-positive non-small cell lung cancer helps select the best treatment.

Lung cancer clinical trials at Perlmutter Cancer Center improve outlooks and life expectancy.